Bioorganic and Medicinal Chemistry Letters p. 2143 - 2147 (2018)
Update date:2022-08-29
Topics:
Martin, Matthew W.
Lee, Jennifer Y.
Lancia, David R.
Ng, Pui Yee
Han, Bingsong
Thomason, Jennifer R.
Lynes, Maureen S.
Marshall, C. Gary
Conti, Chiara
Collis, Alan
Morales, Monica Alvarez
Doshi, Kshama
Rudnitskaya, Aleksandra
Yao, Lili
Zheng, Xiaozhang
N-Hydroxy-2-arylisoindoline-4-carboxamides are potent and selective inhibitors of HDAC11. The discovery, synthesis, and structure activity relationships of this novel series of inhibitors are reported. An advanced analog (FT895) displays promising cellular activity and pharmacokinetic properties that make it a useful tool to study the biology of HDAC11 and its potential use as a therapeutic target for oncology and inflammation indications.
View MoreContact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
Baoding City Light Industry And Textiles Imp.& Exp. Corp. Chemical Department.
Contact:86-312-3262436
Address:NO.658 CHAOYANG SOUTH STREET,BAODING CITY HEBEI CHINA
Longhui qunfeng Chemical Co., Ltd
Contact:86-731-82173407
Address:South-east Industrial Park, Longhui County, Hunan Province, China
Contact:+86-531-58668191 58668193 58668196 58661173
Address:No 55,Beixiaoxinzhuang West Street,Jinan City, Shandong Province
Daicel Chiral Technologies (China)CO.,LTD
Contact:021-5046-0086*8
Address:Part C, FL 5, the 16th Building, No. 69, XiYa Road, WaiGaoQiao Free Trade Zone, Shanghai, 200131, P.R.China
Doi:10.1039/c39890000997
(1989)Doi:10.1016/S0022-1139(00)80531-X
(1986)Doi:10.1016/0022-4596(90)90194-3
(1990)Doi:10.1006/bioo.2000.1187
(2000)Doi:10.1016/j.catcom.2014.04.006
(2014)Doi:10.1246/cl.2008.64
(2008)